1 outlets · filed 29 October 2026
We're raising our price target on Eli Lilly as the obesity-drug boom rolls on
This story is from the archive. It was covered between
29 October 2026 and
29 October 2026, and nothing
below has been updated since. See what is happening now.
The Lilly train keeps on rolling thanks to Mounjaro and Zepbound. And there's more growth to be had.
How it broke
29 Oct 17:44
CNBCFirst
We're raising our price target on Eli Lilly as the obesity-drug boom rolls on
CNBC
In this story
Get the 5 stories every outlet is covering, every morning. Free.
One email a day. Unsubscribe in one click. We host no journalism and never sell your address.
More on Health
- Indonesia factory fire kills three, 36 missing 3 outlets
- Mexican drug lord on FBI's 10 most wanted list arrested in shoot-out 3 outlets
- Princess of Wales opens up about cancer 2 outlets
- Princess Kate reflects on healing in new documentary: "Cancer does change you" 2 outlets
- Violence breaks out in Mexico after capture of drug kingpin wanted by FBI 2 outlets
